Toxic effects and bioaccumulation of carbamazepine evaluated by biomarkers measured in organisms of different trophic levels

Chemosphere

Volumn 80, Issue 9, 2010, Pages 1062-1068

  Vernouillet, Gabrielle ^a   Eullaffroy, Philippe ^b   Lajeunesse, André ^c   Blaise, Christian ^c   Gagné, François ^c   Juneau, Philippe ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c ENVIRONMENT CANADA   (Canada)

Author keywords

Bioaccumulation; Carbamazepine; Enzymatic biomarkers; Toxicity; Trophic chain

Indexed keywords

AMIDES; BIOACCUMULATION; BIOMARKERS; ENZYME ACTIVITY; ENZYME INHIBITION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; REDOX REACTIONS; SEWAGE; TOXICITY; WASTEWATER TREATMENT; WATER TREATMENT;

BIOACCUMULATION FACTOR; CARBAMAZEPINE; GLUTATHIONE S-TRANSFERASES; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; PSEUDOKIRCHNERIELLA SUBCAPITATA; SEWAGE WATER TREATMENT PLANTS; THAMNOCEPHALUS PLATYURUS; TROPHIC CHAINS;

AQUATIC ORGANISMS;

BENZIDINE; BIOLOGICAL MARKER; CARBAMAZEPINE; CYTOCHROME; CYTOCHROME P450; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEME; HEME OXIDASE; UNCLASSIFIED DRUG;

BIOACCUMULATION; BIOMARKER; CRUSTACEAN; DRUG; ENZYME ACTIVITY; EXPERIMENTAL STUDY; GREEN ALGA; INHIBITION; LIQUID CHROMATOGRAPHY; POLYP; REDOX CONDITIONS; SEWAGE TREATMENT; TOXICITY TEST; TROPHIC LEVEL; WATER POLLUTION;

AEROBIC METABOLISM; ARTICLE; BIOACCUMULATION; COELENTERATE; CONTROLLED STUDY; CRUSTACEA; ENZYME ACTIVITY; FOOD CHAIN; GREEN ALGA; HYDRA ATTENUATA; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; NONHUMAN; OXIDATIVE STRESS; PSEUDOKIRCHNERIELLA SUBCAPITATA; TANDEM MASS SPECTROMETRY; THAMNOCEPHALUS PLATYURUS;

ALGAE; CHLOROPHYTA; CRUSTACEA; HYDRA VULGARIS; SELENASTRUM CAPRICORNUTUM; THAMNOCEPHALUS PLATYURUS;

EID: 77955171886     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2010.05.010     Document Type: Article

References (71)

1. Adibhatla R.M., Hatcher J.F. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J. Neurosci. Res. 2003, 73(3):308-315.
2. Ahel M., McEvoy J., et al. Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms. Environ. Pollut. 1993, 79(3):243-248.
3. Anzenbacher P., Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol. Life Sci. 2001, 58(5-6):737-747.
4. Ayscough, N.J., Fawell J., et al., 2001. Review of Human Pharmaceuticals in the Environment. R&D Technical Support: 390.
5. Bazinet R.P., Rao J.S., et al. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol. Psychiatry 2006, 59(5):401-407.
6. Blaise C. Micromethod for acute aquatic toxicity assessment using the green alga Selenastrum capricornutum. Toxic. Assess. 1986, 1:377-385.
7. Blaise, C., 2000. Canadian Application of Microbiotests to Assess the Toxic Potential of Complex Liquid and Solid Media. New Microbiotests for Routine Toxicity Screening and Biomonitoring, vol. 1, pp. 3-12.
8. Blaise C., Kusui T. Acute toxicity assessment of industrial effluents with a microplate-based Hydra attenuata assay. Environ. Toxicol. Water Qual. 1997, 12:53-60.
9. Borelli L., Carginale V., et al. Phospholipase A2 and protein kinase C enzymatic activities and their interactions in Hydra vulgaris. Comp. Biochem. Physiol. 1995, 111(2):211-219.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
11. Buhler D.R., Wang-Buhler J.L. Rainbow trout cytochrome P450s: purification, molecular aspects, metabolic activity, induction and role in environmental monitoring. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 1998, 121(1-3):107-137.
12. Chen M., Ohman K., et al. Pharmaceuticals and endocrine disruptors in wastewater treatment effluents and in the water supply system of Calgary, Alberta, Canada. Water Qual. Res. J. Can. 2006, 41(4):351-364.
13. Clara M., Strenn B., et al. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38(4):947-954.
14. Connon R., Dewhurst R.E., et al. Haem peroxidase activity in Daphnia magna: a biomarker for sub-lethal toxicity assessments of kerosene-contaminated groundwater. Ecotoxicology 2003, 12(5):387-395.
15. Coogan M.A., Edziyie R.E., et al. Algal bioaccumulation of triclocarban, triclosan, and methyl-triclosan in a North Texas wastewater treatment plant receiving stream. Chemosphere 2007, 67(10):1911-1918.
16. Correa-Reyes G., Viana M.T., et al. Nonylphenol algal bioaccumulation and its effect through the trophic chain. Chemosphere 2007, 68(4):662-670.
17. Creasel, 1996. Algaltoxkit F™, Freshwater Toxicity Test with Microalgae. Standard Operational Procedure. Deinze, Belgium, p. 28.
18. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107(Suppl. 6):907-938.
19. Decker E.A., Erickson M.C., et al. Enzymic lipid oxidative activities of sarcoplasmic reticulum in several species of northwest Atlantic fish. Comp. Biochem. Physiol. C 1988, 91:7-9.
20. Delepee R., Pouliquen H., et al. The bryophyte Fontinalis antipyretica Hedw. Bioaccumulates oxytetracycline, flumequine and oxolinic acid in the freshwater environment. Sci. Total Environ. 2004, 322(1-3):243-253.
21. Fent K., Weston A.A., et al. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76(2):122-159.
22. Ferrari B., Mons R., et al. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ. Toxicol. Chem. 2004, 23(5):1344-1354.
23. Foyer C.H., Lelandais M., et al. Photooxidative stress in plants. Physiol. Plant. 1994, 92:696-717.
24. Foyer C.H., Lopez-Delgado H., et al. Hydrogen peroxide- and glutathione-associated mechanisms of acclamatory stress tolerance and signalling. Physiol. Plant. 1997, 100(241).
25. Gagné F., Blaise C., et al. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicol. Environ. Saf. 2006, 64(3):329-336.
26. Galen D. Culturing Methods for Hydra The American Biology Teacher 1969, 31(3):174-177.
27. Geoffroy, L., Couderchet M., et al., 2001. Effet du diuron, de l'oxyfluorfene et du cuivre sur l'activité catalasique de Scenedesmus obliquus. Produits phytosanitaires. Analyse, résidus, métabolites, écotoxicologie, modes d'action, transfert. M. Couderchet, P. Eullaffroy and G. Vernet. Reims, France, Presses Universitaires de Reims, pp. 157-166.
28. Ghelardoni S., Tomita Y.A., et al. Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol. Psychiatry 2004, 56(4):248-254.
29. Habig W.H., Pabst M.J., et al. Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249(22):7130-7139.
30. Halliwell B., Foyer C. Properties and physiological function of a glutathione reductase purified from spinach leaves by affinity chromatography. Planta 1978, 139:9-17.
31. Hillebrand H., Dürselen C.D., et al. Biovolume calculation for pelagic and benthic microalgae. J. Phycol. 1999, 35(2):403-424.
32. Ikenaka, Y., Ishizuka M., et al., 2006. Cytochrome P450 in aquatic crustacean Daphnia magna. Direct Submission to NCBI, Yoshinori Ikenaka, Shinshu University, Research and Education Center for Inlandwater Environment; Kogandori 5-2-4, Suwa, Nagano 392-0027, Japan.
33. Janknegt P.J., Rijstenbil J.W., et al. A comparison of quantitative and qualitative superoxide dismutase assays for application to low temperature microalgae. J. Photochem. Photobiol. B 2007, 87(3):218-226.
34. Joubert G. A bioassay application for quantitative toxicity measurements, using the green algae Selenastrum capricornutum. Water Res. 1980, 14:1759-1763.
35. Juneau P., Dewez D., et al. Evaluation of different algal species sensitivity to mercury and metolachlor by PAM-fluorometry. Chemosphere 2001, 45(4):589-598.
36. Lajeunesse A., Gagnon C. Determination of acidic pharmaceutical products and carbamazepine in roughly primary-treated wastewater by solid-phase extraction and gas chromatography-tandem mass spectrometry. Int. J. Environ. Anal. Chem. 2007, 87(8):565-578.
37. Lajeunesse A., Vernouillet G., et al. Determination of carbamazepine in aquatic organisms by liquid-liquid extraction and liquid chromatography-tandem mass spectrometry. J. Environ. Monit. 2009, 11(4):723-725.
38. Laville N., Ait-Aissa S., et al. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196(1-2):41-55.
39. Merchant S.S., Prochnik S.E., et al. The Chlamydomonas genome reveals the evolution of key animal and plant functions. Science 2007, 318(5848):245-250.
40. Metcalfe C.D., Koenig B.G., et al. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ. Toxicol. Chem. 2003, 22(12):2872-2880.
41. Mittler R., Vanderauwera S., et al. Reactive oxygen gene network of plants. Trends Plant Sci. 2004, 9(10):490-498.
42. Nalecz-Jawecki G., Persoone G. Toxicity of selected pharmaceuticals to the anostracan crustacean Thamnocephalus platyurus: comparison of sublethal and lethal effect levels with the 1h Rapidtoxkit and the 24h Thamnotoxkit microbiotests. Environ. Sci. Pollut. Res. Int. 2006, 13(1):22-27.
43. Nguyen, D.-L., 2005. Isolation and Characterization of Cytochrome P450 Genes in Barley. Centre for Plant Conservation Genetics, Southern Cross University, PO Box 157, Military Road, Lismore, NSW 2480, Australia.
44. Nimrod A.C., Benson W.H. Environmental estrogenic effects of alkylphenol ethoxylates. Crit. Rev. Toxicol. 1996, 26(3):335-364.
45. O'Donovan D.J., Katkin J.P., et al. Gene transfer of mitochondrially targeted glutathione reductase protects H441 cells from t-butyl hydroperoxide-induced oxidant stresses. Am. J. Respir. Cell Mol. Biol. 1999, 20(2):256-263.
46. Peakall D.B., Walker C.H. The role of biomarkers in environmental assessment. (3) Vertebrates. Ecotoxicology 1994, 3(3):173-179.
47. Pearce R.E., Lu W., et al. Pathways of carbamazepine bioactivation in vitro: III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine. Drug Metab. Dispos. 2008, 36(8):1637-1649.
48. Pearce R.E., Uetrecht J.P., et al. Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene. Drug Metab. Dispos. 2005, 33(12):1819-1826.
49. Pearce R.E., Vakkalagadda G.R., et al. Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites. Drug Metab. Dispos. 2002, 30(11):1170-1179.
50. Persoone G., Janssen C., et al. Cyst-based toxicity tests X: comparison of the sensitivity of the acute Daphnia magna test and two crustacean microbiotests for chemicals and wastes. Chemosphere 1994, 29(12):2701-2710.
51. Pirmohamed M., Kitteringham N.R., et al. The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes. Biochem. Pharmacol. 1992, 44(12):2307-2314.
52. Quinn B., Gagne F., et al. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata. Sci. Total Environ. 2008, 389(2-3):306-314.
53. Quinn B., Gagné F., et al. Oxidative metabolism activity in Hydra attenuata exposed to carbamazepine. Fresenius Environ. Bull. 2004, 13:783-788.
54. Ralph P.J., Smith R.A., et al. Use of fluorescence-based ecotoxicological bioassays in monitoring toxicants and pollution in aquatic systems: review. Toxicol. Environ. Chem. 2007, 89(4):589-607.
55. Rivera, M.A.J., Howarth F.G., et al., 1999. Direct Submission. Division of Insect Biology, Department of Environmental Science, Policy and Management, University of California Berkeley, 201 Wellman Hall, Berkeley, CA 94720-3112, USA.
56. Schwaiger J., Ferling H., et al. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68(2):141-150.
57. Seiler R.L., Zaugg S.D., et al. Caffeine and pharmaceuticals as indicators of waste water contamination in wells. Ground Water 1999, 37(3):405-410.
58. Servos M. Review of the aquatic toxicity, estrogenic responses and bioaccumulation of alkylphenols and alkylphenol polyethoxylates. Water Qual. Res. J. Can. 1999, 34(1):123-177.
59. Smith I.K., Vierheller T.L., et al. Assay of glutathione reductase in crude tissue homogenates using 5, 5'-dithiobis(2-nitrobenzoic acid). Anal. Biochem. 1988, 175:408-413.
60. Spina E., Pisani F., et al. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin. Pharmacokinet. 1996, 31(3):198-214.
61. Stresser D.M., Blanchard A.P., et al. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab. Dispos. 2000, 28(12):1440-1448.
62. Teisseire H., Vernet G. Is the " diuron effect" due to a herbicide strengthening of antioxidative defenses of Lemna minor?. Pesticide Biochem. Physiol. 2000, 66:153-160.
63. Teisseire H., Vernet G. Effects of the fungicide folpet on the activities of antioxidative enzymes in duckweed (Lemna minor). Pesticide Biochem. Physiol. 2001, 69:1126117.
64. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32(11):3245-3260.
65. Thamnotoxkit, F., 1995. Crustacean Toxicity Screening Test for Freshwater. Standard Operational Procedure. MicroBioTests Inc., Nazareth, Belgium. 23p.
66. Thomas P.E., Ryan D., et al. Improved staining procedure for the detection of the peroxidase activity of cytochrome P450 on sodium dodecyl sulfate polyacrylamide gels. Anal. Biochem. 1976, 75:168-176.
67. Voutsas E., Magoulas K., et al. Prediction of the bioaccumulation of persistent organic pollutants in aquatic food webs. Chemosphere 2002, 48(7):645-651.
68. Webb S. A data bases perspective on the environmental risk assessment of human pharmaceuticals. Aquatic risk characterization. Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks 2001, 205-219. Springer-Verlag, Berlin. first ed. K. kummerer (Ed.).
69. Zhang Y., Geissen S.U., et al. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73(8):1151-1161.
70. Zhou J.L., Zhang Z.L., et al. Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J. Hazard Mater. 2009, 166(2-3):655-661.
71. Zuccato E., Calamari D., et al. Presence of therapeutic drugs in the environment. Lancet 2000, 355(9217):1789-1790.